Guangzhou Yizheng Pharmaceutical Co., Ltd. (abbreviated as GH) is primarily engaged in the introduction, promotion, and sales services of pharmaceutical-related products such as new drugs, generic drugs, and medical devices; import and export business of active pharmaceutical ingredients (APIs) and intermediates; as well as information search, registration and application, market planning, and promotion of new varieties. The company is headquartered in Guangzhou. GH's development direction is to become a modern pharmaceutical enterprise renowned domestically and internationally, trustworthy, and capable of attracting active collaboration from international pharmaceutical companies and well-known domestic pharmaceutical enterprises, specializing in the research, introduction, promotion, and sales of new drugs, APIs, and prescription preparations. GH has over 10 years of experience in the registration of imported drugs and medical devices, having successfully registered more than 80 imported products. Currently, it holds more than 10 API import registration certificates, with over 40 products under application or preparation. GH is proficient in sourcing high-quality and unique pharmaceutical-related products from abroad, as well as in registration applications, import customs clearance, and port drug inspection, establishing a modern communication and service platform for domestic pharmaceutical companies to access excellent international pharmaceutical resources. GH boasts an expert academic clinical promotion team, integrating resources from registration applications to import and sales through multiple channels, contributing to the competitive edge of domestic pharmaceutical enterprises under the new landscape of future medical reforms. Our main businesses include: 1. Providing licensed imported and domestic APIs, preparations, medical devices, and other pharmaceutical-related products; 2. Acting as an agent for drugs and medical devices and conducting clinical promotion; 3. Handling registration applications for imported APIs, preparations, medical devices, and other pharmaceutical-related products; 4. Exporting domestic APIs and preparations and handling overseas registration.